Latest Ratios: P/E Ratio -0.1x · EV/EBITDA N/A · ROE N/A. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $15M | $25M | $19M | $148M | $1.1B | $2.3B | $2.5B |
| Enterprise Value | $16M | $27M | $29M | $156M | $1.1B | $2.3B | $2.5B |
| P/E Ratio → | -0.06 | — | — | — | — | — | — |
| P/S Ratio | — | — | 127.39 | 71.08 | 755.74 | 6234.30 | 3571.88 |
| P/B Ratio | — | — | — | — | — | 7.68 | 192.03 |
| P/FCF | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | 188.33 | 74.58 | 770.40 | 6233.02 | 3559.76 |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | -1349.8% | -173.1% | -237.4% | -368.9% | -300.7% |
| Operating Margin | — | — | -8644.7% | -1047.0% | -971.8% | -2491.6% | -1450.6% |
| Net Profit Margin | — | — | -22688.8% | -992.9% | -980.9% | -2491.3% | -1592.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | -9.8% | -5.9% | -85.6% |
| ROA | -278.5% | -278.5% | -393.7% | -174.8% | -8.1% | -5.4% | -80.5% |
| ROIC | — | — | — | -1286.0% | -6.8% | -4.5% | — |
| ROCE | — | — | — | -4071.4% | -8.9% | -5.5% | -77.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — |
| Net Debt / Equity | — | — | — | — | — | -0.00 | -0.65 |
| Net Debt / EBITDA | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — |
| Interest Coverage | -6.27 | -6.27 | -9.31 | -26.44 | -79.61 | — | -5.67 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.75 | 0.75 | 0.09 | 0.43 | 0.28 | 0.15 | 13.08 |
| Quick Ratio | 0.65 | 0.65 | 0.02 | 0.28 | 0.25 | 0.05 | 12.03 |
| Cash Ratio | 0.40 | 0.40 | 0.01 | 0.21 | 0.10 | 0.12 | 11.92 |
| Asset Turnover | — | — | 0.02 | 0.20 | 0.11 | 0.00 | 0.05 |
| Inventory Turnover | 0.03 | 0.03 | 1.44 | 3.91 | 5.00 | 4.31 | 3.74 |
| Days Sales Outstanding | — | — | — | 84.41 | 82.91 | 216.36 | 27.94 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $32M | $6M | $5M | $3M | $6M | $6M |
Liquidity exhaustion and insolvency
As reported in recent financial statements, Nuburu's ROIC of -53.8% in 2026Q1 highlights a severe inability to generate returns on invested capital, reflecting a structural decay that persists despite the company's ongoing efforts to commercialize its proprietary blue laser technology within the competitive industrial machinery sector.
The deeply negative ROIC suggests that every dollar of capital deployed into the business is currently destroying shareholder value rather than compounding it. This trend appears to be driven by the company's inability to achieve the necessary scale to offset high fixed costs, warranting further investigation into whether the current business model can ever reach a break-even point.
Based on the 2026Q1 data, the company's cash conversion cycle of 2,843 days, as derived from reported figures, underscores extreme inefficiencies in managing inventory and receivables, suggesting that the firm's operational processes are currently disconnected from the realities of a standard industrial manufacturing sales cycle.
The exceptionally high DSO and DIO figures imply that the company is struggling to convert its specialized laser inventory into cash, which is a critical failure for a firm with limited liquidity. Investors should monitor whether these metrics are a result of long-term project-based contracts or a fundamental inability to move product in the current market environment.
According to the latest quarterly filings, Nuburu's current ratio of 0.56 indicates a significant liquidity shortfall, as the company's ability to cover its short-term obligations appears increasingly compromised by the lack of consistent revenue generation and the ongoing depletion of its cash reserves.
A current ratio below 1.0 suggests that the company may be forced to rely on external financing or dilutive capital raises to maintain basic operations. This liquidity position leaves little room for error, and any further delays in commercial adoption could lead to a critical funding gap.
As disclosed in recent balance sheet data, the company's debt-to-equity ratio of 12.80 in 2026Q1 highlights a heavy reliance on external leverage, which, when compared to the firm's negative operating margins, suggests that debt service capacity is currently non-existent and warrants extreme caution from potential investors.
The high leverage ratio in the context of persistent net losses indicates that the company is essentially operating on borrowed time and capital. This structure creates a precarious situation where the firm's survival is tied to its ability to secure additional funding rather than its ability to generate cash from core operations.
Based on the company's current financial profile, the use of P/E or EV/EBITDA multiples is fundamentally misapplied, as these metrics obscure the reality that Nuburu is currently a pre-revenue or early-stage commercial entity rather than a mature industrial firm with stable, predictable earnings power.
Applying traditional valuation multiples to a company with negative margins and volatile revenue growth leads to misleading conclusions about its intrinsic value. Instead, analysts should focus on cash runway and the strategic value of the patent portfolio, as these are the primary drivers of the company's current market positioning.
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BURU stock.
Nuburu, Inc.'s current P/E ratio is -0.1x. This places it at the 50th percentile of its historical range.
Based on historical data, Nuburu, Inc. is trading at a P/E of -0.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.